Biosimilars Market 2022-2028

Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Any differences are carefully evaluated by manufacturers and reviewed by the FDA to ensure the biosimilar meets the Agency’s appropriately high approval standards.

Source: https://www.bharatbook.com/report/1346623/global-biosimilars-market